Home » Newsletters » BioWorld Science

BioWorld Science

March 21, 2019

View Archived Issues

Coming up for air

Vaxart initiates bivalent norovirus vaccine phase Ib study

Engineered protein can block "undruggable" oncogene

Alexion and Zealand Pharma collaborate to discover and develop novel peptide therapies

SOX2OT as a novel prognostic biomarker in bladder cancer

SIRS and hypoxemia in acute pancreatitis could be patient selection factors in studies of CM-4620

HSJ-633 prevents inflammation-induced preterm birth and fetal tissue injury in vivo

Aptevo initiates dosing in phase I study of APVO-210

Cancer gene therapy VB-111 has immunotherapeutic effects in resistant ovarian cancer

Ovarian cancer vaccine DCVAC/OvCa significantly improves survival in phase II trial

Hexima reports findings from second part of phase I/IIa onychomycosis study of HXP-124

Innovent initiates Chinese phase IIa study of IBI-306 for hypercholesterolemia

Knopp Biosciences enters collaboration to initiate phase II trial of dexpramipexole

Hangzhou Pulve Biotechnology describes chimeric antigen receptors targeting mesothelin

Chinese Academy of Sciences patents collagen-targeting VEGF

Merck & Co. identifies adenosine A2A and/or A2B receptor antagonists

Protein disulfide-isomerase inhibitors discovered at MUSC Foundation for Research Development

Genzada initiates phase I trial of GZ17-6.02 in advanced solid tumors and lymphoma

Vivace Therapeutics presents YAP1/TEAD interaction inhibitors

FDA approves Sunosi for excessive daytime sleepiness associated with narcolepsy or OSA

Genenta intiates phase I/II studies of Temferon in glioblastoma and multiple myeloma

First patient dosed in phase II RAIN-701 study of tarloxotinib in NSCLC

NapaJen, Astellas enter collaboration for development of novel oligonucleotides

Phase III ENGAGE and EMERGE studies of aducanumab in Alzheimer's to end based on futility analysis

Enterome announces collaboration with Dana-Farber on microbiome-derived cancer immunotherapy

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 30, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...